| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Analysts Are Bullish On ACM Research, Inc. (ACMR) | ||
| Fr | L1 Capital International Trimmed HCA Healthcare (HCA) Following Share Price Appreciation | ||
| Fr | L1 Capital International Sold Eagle Materials (EXP). Here's Why | ||
| Do | Strong Momentum in Block (XYZ)'s Square and Cash App Segments Drives UBS' Bullish Stance | ||
| Do | Nebius Group N.V. (NBIS) Co-Founder Sees Huge AI Demand Ahead Backed by Mega Microsoft, Meta Deals | ||
| Do | Bullish Analyst Sentiment on Wix.com (WIX) Despite CFRA's Lowered Target and Slower Growth Outlook | ||
| Do | Datadog (DDOG) Sees Bullish Analyst Stance Amid Strong AI and Observability Momentum Despite Recent Stock Pullback | ||
| Do | ServiceNow (NOW) Deepens Its Long-Term Commitment to Canada with CA$110 Million Investment; Analysts Remain Bullish | ||
| Do | Bullish Analyst Sentiment on Salesforce (CRM) Amid Expanding Enterprise Demand and Strong Q3 Results | ||
| Do | U.S. Approves NVIDIA's (NVDA) H200 Processor Exports to China, CEO Flags China's AI Infrastructure Advantage | ||
| Do | Bullish Analyst Sentiment on Meta Platforms (META) Amid AI Wearables Acquisition and Next-Generation Hardware Plans | ||
| Do | Guggenheim Initiates Coverage of Amazon.com (AMZN) with "Buy" Rating and $300 Price Target | ||
| Do | Stifel Defends Marvell's (MRVL) ASIC Leadership Amid AI Chip Market Rumors | ||
| Do | Vertiv (VRT) Cut to Peerperform as Wolfe Sees Balanced Risk-Reward | ||
| Do | HSBC Initiates Micron (MU) With Buy Rating and $330 Price Target | ||
| Do | Legend Biotech Corporation (LEGN) is an Outperform on Multiple Myeloma Treatment CARVYKTI Prospects | ||
| Do | This is why Viking Therapeutics, Inc. (VKTX) is a Strong Buy on Wall Street | ||
| Do | Citi Asserts Buy Rating on Summit Therapeutics Inc. (SMMT) on Pipeline Development | ||
| Do | UBS Reiterates Neutral on Apple (AAPL) as App Store Growth Slows | ||
| Do | Vaxcyte, Inc. (PCVX) Makes Strides on Pneumonia Treatment, Plots Coverage Extension | ||
| Do | Wall Street Firms Tout Corcept Therapeutics Incorporated (CORT) Prospects on Korlym Medication Prospects | ||
| Do | Crinetics Pharmaceuticals (CRNX) Poised for Transformational Growth in 2026: Piper Sandler | ||
| Do | Needham Boosts Ciena (CIEN) Price Target to $240 Ahead of Earnings | ||
| Do | Why These Energy Stocks are Losing This Week | ||
| Do | Bellring Brands (BRBR) Jumps 9% as Fed Rate Cut Sparks Higher Consumer Spending |